А. Э. Гареева

685 total citations
25 papers, 199 citations indexed

About

А. Э. Гареева is a scholar working on Molecular Biology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, А. Э. Гареева has authored 25 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Psychiatry and Mental health. Recurrent topics in А. Э. Гареева's work include Genetic Associations and Epidemiology (7 papers), Tryptophan and brain disorders (5 papers) and Schizophrenia research and treatment (5 papers). А. Э. Гареева is often cited by papers focused on Genetic Associations and Epidemiology (7 papers), Tryptophan and brain disorders (5 papers) and Schizophrenia research and treatment (5 papers). А. Э. Гареева collaborates with scholars based in Russia, United States and United Kingdom. А. Э. Гареева's co-authors include Э. К. Хуснутдинова, Jennifer L. Gibbs, Julia Eisenberg, А. В. Казанцева, Т. В. Наседкина, Nela Pivac, Darya Gaysina, Mladen Jokić, Gordana Nedić Erjavec and Tanel Traks and has published in prestigious journals such as Progress in Neuro-Psychopharmacology and Biological Psychiatry, Higher Education and American Behavioral Scientist.

In The Last Decade

А. Э. Гареева

21 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. Э. Гареева Russia 8 48 43 41 39 38 25 199
Carlo Berti United Kingdom 9 61 1.3× 23 0.5× 91 2.2× 32 0.8× 42 1.1× 30 293
Jianjun Yao China 7 29 0.6× 15 0.3× 51 1.2× 49 1.3× 146 3.8× 14 330
Jeffrey L. Crawford United States 8 55 1.1× 14 0.3× 38 0.9× 46 1.2× 24 0.6× 15 308
Fernanda Machado Lopes Brazil 11 37 0.8× 7 0.2× 11 0.3× 74 1.9× 38 1.0× 60 384
Gamze Erzın Türkiye 9 6 0.1× 13 0.3× 59 1.4× 17 0.4× 69 1.8× 34 243
Jessica S. Flannery United States 8 47 1.0× 7 0.2× 37 0.9× 25 0.6× 27 0.7× 21 299
Fumihiko Ueno Canada 8 40 0.8× 8 0.2× 18 0.4× 17 0.4× 36 0.9× 25 161
Anna N. Ligezka United States 10 7 0.1× 5 0.1× 40 1.0× 112 2.9× 32 0.8× 21 263
Patricia M. Ball United States 8 44 0.9× 19 0.4× 286 7.0× 23 0.6× 14 0.4× 15 447

Countries citing papers authored by А. Э. Гареева

Since Specialization
Citations

This map shows the geographic impact of А. Э. Гареева's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. Э. Гареева with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. Э. Гареева more than expected).

Fields of papers citing papers by А. Э. Гареева

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. Э. Гареева. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. Э. Гареева. The network helps show where А. Э. Гареева may publish in the future.

Co-authorship network of co-authors of А. Э. Гареева

This figure shows the co-authorship network connecting the top 25 collaborators of А. Э. Гареева. A scholar is included among the top collaborators of А. Э. Гареева based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. Э. Гареева. А. Э. Гареева is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Гареева, А. Э., et al.. (2024). Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors. S S Korsakov Journal of Neurology and Psychiatry. 124(6). 26–26. 1 indexed citations
2.
Гареева, А. Э.. (2023). Genome-Wide Association Study of the Risk of Schizophrenia in the Republic of Bashkortostan. Russian Journal of Genetics. 59(8). 831–839.
3.
4.
Гареева, А. Э.. (2023). Genome-Wide Association Study of the Risk of Schizophrenia in the Republic of Bashkortostan. Генетика. 59(8). 954–963.
5.
Казанцева, А. В., et al.. (2021). The association study of polymorphic variants of hypothalamic-pituitary-adrenal system genes (AVPR1B, OXTR) and aggressive behavior manifestation: a focus on social environment. Open Access Repository (Belgorod State National Research University). 7(3). 232–244. 2 indexed citations
6.
Гареева, А. Э., et al.. (2020). The combined effect of genetic factors and attention deficit hyperactivity disorder on the development of dependence on synthetic cannabinoids. S S Korsakov Journal of Neurology and Psychiatry. 120(2). 15–15. 1 indexed citations
7.
Гареева, А. Э., et al.. (2020). Combined Influences of Genetic Factors and Attention Deficit Hyperactivity Disorder on the Development of Dependence on Synthetic Cannabinoids. Neuroscience and Behavioral Physiology. 50(9). 1105–1111. 1 indexed citations
8.
Гареева, А. Э. & Э. К. Хуснутдинова. (2020). The Role of Intergenic Interactions of Neurotrophic and Neurotransmitter System Genes in the Development of Susceptibility to Paranoid Schizophrenia. Russian Journal of Genetics. 56(1). 79–87. 1 indexed citations
9.
Гареева, А. Э. & Э. К. Хуснутдинова. (2018). Schizophrenia Genetics. Russian Journal of Genetics. 54(6). 593–603. 2 indexed citations
10.
11.
Гареева, А. Э., et al.. (2015). Polymorphism of brain neurotransmitter system genes: Search for pharmacogenetic markers of haloperidol efficiency in Russians and Tatars. Molecular Biology. 49(6). 858–866. 6 indexed citations
12.
Гареева, А. Э. & Э. К. Хуснутдинова. (2015). [Glutamate receptors genes polymorphism and the risk of paranoid schizophrenia in Russians and tatars from the Republic of Bashkortostan].. PubMed. 48(5). 771–81. 2 indexed citations
13.
Гареева, А. Э., Tanel Traks, Sulev Kõks, & Э. К. Хуснутдинова. (2015). The role of neurotrophins and neurexins genes in the risk of paranoid schizophrenia in Russians and Tatars. Russian Journal of Genetics. 51(7). 683–694. 6 indexed citations
14.
Gibbs, Jennifer L., et al.. (2014). The “Megapozitiv” Role of Enterprise Social Media in Enabling Cross-Boundary Communication in a Distributed Russian Organization. American Behavioral Scientist. 59(1). 75–102. 48 indexed citations
15.
Гареева, А. Э., et al.. (2014). Ассоциация полиморфных маркеров геновSLC18A1,TPH1иRELNс риском развития параноидной формы шизофрении. Молекулярная биология. 48(4). 629–639. 1 indexed citations
16.
Гареева, А. Э., et al.. (2014). Association of SLC18A1, TPH1, and RELN gene polymorphisms with risk of paranoid schizophrenia. Molecular Biology. 48(4). 546–555. 17 indexed citations
17.
Гареева, А. Э. & Э. К. Хуснутдинова. (2014). Polymorphism of the glutamate receptor genes and risk of paranoid schizophrenia in Russians and Tatars from the Republic of Bashkortostan. Molecular Biology. 48(5). 671–680. 4 indexed citations
18.
19.
Казанцева, А. В., et al.. (2009). Association of several polymorphic loci of serotoninergic genes with unipolar depression. Russian Journal of Genetics. 45(6). 742–748. 7 indexed citations
20.
Pivac, Nela, Gordana Nedić Erjavec, А. В. Казанцева, et al.. (2008). Ethnic differences in the serotonin transporter polymorphism (5-HTTLPR) in several European populations. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(7). 1735–1739. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Berti Breakdown of academic impact, for papers by Jianjun Yao Breakdown of academic impact, for papers by Jeffrey L. Crawford Breakdown of academic impact, for papers by Fernanda Machado Lopes Breakdown of academic impact, for papers by Gamze Erzın Breakdown of academic impact, for papers by Jessica S. Flannery Breakdown of academic impact, for papers by Fumihiko Ueno Breakdown of academic impact, for papers by Anna N. Ligezka Breakdown of academic impact, for papers by Patricia M. Ball
Rankless by CCL
2026